10.1038/s41467-020-19055-7 - A nanoluciferase SARS-CoV-2 for rapid...

This document has been corrected

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

10.1038/s41467-020-19055-7

Published Online: 2020-10-15

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Antonio E. Muruato•Camila R. Fontes-Garfias•Chien-Te K. Tseng•Jianying Liu•Jing Zou•John P. Bilello•Kumari G. Lokugamage•Mini Balakrishnan•Pei-Yong Shi•Ping Ren•Shinji Makino•Tomas Cihlar•Vineet D. Menachery•Xianwen Zhang•Xuping Xie

This document has been corrected

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

10.1038/s41467-020-19055-7

Published Online: 2020-10-15

Journal: Nature Communications

NOW

2021-06-21•Correction

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

10.1038/s41467-021-24300-8

* information provided by CrossRef

2021-06-21•Correction

10.1038/s41467-021-24300-8

* information provided by CrossRef

2020-10-15•Published

2021-06-21•Correction

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

10.1038/s41467-021-24300-8

* information provided by CrossRef

This document has been corrected

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

10.1038/s41467-020-19055-7

Published Online: 2020-10-15

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC